Research graph
References from Examination of the effectiveness of Si-based agent in radiotherapy using the alpha-emitting nuclide astatine. Local targets link to admitted publications; unresolved targets remain external evidence.
Enhancement of 211At uptake via the sodium iodide symporter by the addition of ascorbic acid in targeted α-therapy of thyroid cancer
10.2967/jnumed.118.222638 · 2019 · External reference
Targeted alpha therapy using astatine (211At)-labeled phenylalanine: a preclinical study in glioma bearing mice
10.18632/oncotarget.27552 · 2020 · External reference
Tumor targeting of 211At-labeled antibody under sodium ascorbate protection against radiolysis
10.1021/acs.molpharmaceut.2c00869 · 2023 · External reference
Recent advances in understanding and improving the stability of 211At-radiopharmaceuticals
10.1016/j.nucmedbio.2025.109573 · 2025 · External reference
Hydrogen generation by reaction of Si nanopowder with neutral water
10.1007/s11051-017-3873-z · 2017 · External reference
Renoprotective and neuroprotective effects of enteric hydrogen generation from Si-based agent
10.1038/s41598-020-62755-9 · 2020 · External reference
A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent
10.1038/s41598-022-13655-7 · 2022 · External reference
Effect of the new silicon-based agent on the symptoms of interstitial pneumonitis
10.1038/s41598-023-32745-8 · 2023 · External reference
Si-based agent alleviated small bowel ischemia-reperfusion injury through antioxidant effects
10.1038/s41598-024-54542-7 · 2024 · External reference
Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine
10.1016/j.pharmthera.2014.04.006 · 2014 · External reference
Synthesis of [211At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solution
10.1038/s41598-021-92476-6 · 2021 · External reference
Unresolved reference
2012 · External reference
Vitamin C: the known and the unknown and goldilocks
10.1111/odi.12446 · 2016 · External reference
Vitamin C and immune function
10.3390/nu9111211 · 2017 · External reference
Speciation and redox behavior of astatine in aqueous solution: a combined experimental and theoretical study
10.1021/jp9077008 · 2010 · External reference
Effects of hydrogen-rich water and ascorbic acid treatment on spontaneously hypertensive rats
10.1538/expanim.21-0187 · 2022 · External reference
Hydrogen and vitamin C combination therapy: a novel method of radioprotection
2023 · External reference
Targeting inflammation as cancer therapy
10.1186/s13045-024-01528-7 · 2024 · External reference
The delicate equilibrium between oxidants and antioxidants in brain glioma
10.2174/1570159x16666180302120925 · 2019 · External reference
Antioxidants in brain tumors: current therapeutic significance and future prospects
10.1186/s12943-022-01668-9 · 2022 · External reference
Hydrogen generation by reaction of Si nanopowder with neutral water
10.1007/s11051-017-3873-z · ExternalCitation · doi-reference
Recent advances in understanding and improving the stability of 211At-radiopharmaceuticals
10.1016/j.nucmedbio.2025.109573 · ExternalCitation · doi-reference
Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine
10.1016/j.pharmthera.2014.04.006 · ExternalCitation · doi-reference
Tumor targeting of 211At-labeled antibody under sodium ascorbate protection against radiolysis
10.1021/acs.molpharmaceut.2c00869 · ExternalCitation · doi-reference
Speciation and redox behavior of astatine in aqueous solution: a combined experimental and theoretical study
10.1021/jp9077008 · ExternalCitation · doi-reference
Renoprotective and neuroprotective effects of enteric hydrogen generation from Si-based agent
10.1038/s41598-020-62755-9 · ExternalCitation · doi-reference
Synthesis of [211At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solution
10.1038/s41598-021-92476-6 · ExternalCitation · doi-reference
A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent
10.1038/s41598-022-13655-7 · ExternalCitation · doi-reference
Effect of the new silicon-based agent on the symptoms of interstitial pneumonitis
10.1038/s41598-023-32745-8 · ExternalCitation · doi-reference
Si-based agent alleviated small bowel ischemia-reperfusion injury through antioxidant effects
10.1038/s41598-024-54542-7 · ExternalCitation · doi-reference
Vitamin C: the known and the unknown and goldilocks
10.1111/odi.12446 · ExternalCitation · doi-reference
Antioxidants in brain tumors: current therapeutic significance and future prospects
10.1186/s12943-022-01668-9 · ExternalCitation · doi-reference
Targeting inflammation as cancer therapy
10.1186/s13045-024-01528-7 · ExternalCitation · doi-reference
Effects of hydrogen-rich water and ascorbic acid treatment on spontaneously hypertensive rats
10.1538/expanim.21-0187 · ExternalCitation · doi-reference
Targeted alpha therapy using astatine (211At)-labeled phenylalanine: a preclinical study in glioma bearing mice
10.18632/oncotarget.27552 · ExternalCitation · doi-reference
The delicate equilibrium between oxidants and antioxidants in brain glioma
10.2174/1570159x16666180302120925 · ExternalCitation · doi-reference
Enhancement of 211At uptake via the sodium iodide symporter by the addition of ascorbic acid in targeted α-therapy of thyroid cancer
10.2967/jnumed.118.222638 · ExternalCitation · doi-reference
Vitamin C and immune function
10.3390/nu9111211 · ExternalCitation · doi-reference
